Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy

DIL boosting was found to be feasible with all investigated techniques. Although OAR doses were higher than for standard treatment approach, the risk levels were reasonably low. HDR-BT was superior to VMAT and IMPT, both in terms of OAR sparing and DIL boosting.